BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9711381)

  • 1. Olanzapine after clozapine: the rare case of prolongation of granulocytopaenia.
    Lambert T
    Aust N Z J Psychiatry; 1998 Aug; 32(4):591-2. PubMed ID: 9711381
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of clozapine-induced granulocytopenia associated with olanzapine.
    Flynn SW; Altman S; MacEwan GW; Black LL; Greenidge LL; Honer WG
    J Clin Psychopharmacol; 1997 Dec; 17(6):494-5. PubMed ID: 9408818
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine prolongation of granulocytopenia after clozapine discontinuation.
    Konakanchi R; Grace JJ; Szarowicz R; Pato MT
    J Clin Psychopharmacol; 2000 Dec; 20(6):703-4. PubMed ID: 11106146
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine: safe during clozapine-induced agranulocytosis.
    Oyewumi LK; Al-Semaan Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with clozapine and olanzapine.
    Chatterton R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atypical antipsychotics].
    Heeringa M; van Grootheest AC
    Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2078-9. PubMed ID: 11072513
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X; Wang X
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
    Benedetti F; Cavallaro R; Smeraldi E
    Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
    Iverson S; Zahid N; Uetrecht JP
    Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia.
    Schuld A; Kraus T; Hinze-Selch D; Haack M; Pollmächer T
    Acta Psychiatr Scand; 2000 Aug; 102(2):153-5. PubMed ID: 10937789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent priapism during treatment with clozapine and olanzapine.
    Compton MT; Saldivia A; Berry SA
    Am J Psychiatry; 2000 Apr; 157(4):659. PubMed ID: 10777416
    [No Abstract]   [Full Text] [Related]  

  • 16. Are there genetic determinants of olanzapine-induced agranulocytosis?
    Felber W; Naumann R; Schuler U; Fülle M; Reuster T; Garcia K; Heilemann H
    Pharmacopsychiatry; 2000 Sep; 33(5):197-9. PubMed ID: 11071024
    [No Abstract]   [Full Text] [Related]  

  • 17. [Olanzapine as an alternative in clozapine-induced akathisia?].
    Knoch H; Hofmann M; Seifritz E
    Psychiatr Prax; 1999 Nov; 26(6):308. PubMed ID: 10627963
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
    Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
    Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotic drugs and hyperglycemia in adolescents.
    Koller E; Malozowski S; Doraiswamy PM
    JAMA; 2001 Nov; 286(20):2547-8. PubMed ID: 11722267
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine: hematological reactions.
    CMAJ; 1998 Jul; 159(1):81-2, 85-6. PubMed ID: 9679498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.